Literature DB >> 29091262

Isolation and Functional Use of Human NKT Cells.

Mark A Exley1,2, S Brian Wilson3, Steven P Balk4.   

Abstract

This unit details methods for the isolation, in vitro expansion, and functional characterization of human iNKT cells. The term 'iNKT' derives from the fact that a large fraction of murine and some human NK marker+ T cells ('NKT') recognize the MHC class I-like CD1d protein and use an identical 'invariant' TCRα chain, which is generated in humans by precise Vα24 and Jα18 rearrangements with either no N-region diversity or subsequent trimming to identical or nearly identical amino acid sequence (hence, 'iNKT' cells). iNKT are mostly CD4+ or CD4-CD8- ('double negative'), although a few CD8+ iNKT can be found in some humans. Basic Protocol 1 and Alternate Protocol 1 use multi-color FACS analysis to identify and quantitate rare iNKT cells from human samples. Basic Protocol 2 describes iNKT cell purification. Alternate Protocol 2 describes a method for high-speed FACS sorting of iNKT cells. Basic Protocol 3 explains functional analysis of iNKT. Alternate Protocol 3 employs a cell sorting approach to isolate iNKT cell clones. A support protocol for secondary stimulation and rapid expansion of iNKT cells is also included. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  CD1d; NKT cells; human; iNKT cells; invariant T cell receptor; α-galactosylceramide

Mesh:

Substances:

Year:  2017        PMID: 29091262     DOI: 10.1002/cpim.33

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  5 in total

Review 1.  Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis.

Authors:  Li Chen; Desong Kong; Siwei Xia; Feixia Wang; Zhanghao Li; Feng Zhang; Shizhong Zheng
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

Review 2.  Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment.

Authors:  Gloria Delfanti; Paolo Dellabona; Giulia Casorati; Maya Fedeli
Journal:  Front Med (Lausanne)       Date:  2022-05-09

Review 3.  T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies.

Authors:  Valérie Janelle; Jean-Sébastien Delisle
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

4.  Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis C.

Authors:  Tina Senff; Christopher Menne; Christine Cosmovici; Lia Laura Lewis-Ximenez; Jasneet Aneja; Ruth Broering; Arthur Y Kim; Astrid M Westendorf; Ulf Dittmer; Norbert Scherbaum; Georg M Lauer; Jörg Timm
Journal:  JCI Insight       Date:  2022-01-25

Review 5.  Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy.

Authors:  Benjamin J Wolf; Jiyoung Elizabeth Choi; Mark A Exley
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.